Antibodies to private and public HLA class I epitopes in platelet recipients

Transfusion

Volumn 39, Issue 7, 1999, Pages 772-780

  Zimmermann, Robert ^a   Wittmann, G ^b   Zingsem, J ^b   Blasczyk, R ^b   Weisbach, V ^b   Eckstein, R ^b  

^a UNIVERSITY HOSPITAL ERLANGEN   (Germany)

^b NONE

Author keywords

[No Author keywords available]

Indexed keywords

HLA ANTIBODY; HLA ANTIGEN CLASS 1;

ALLOIMMUNIZATION; ANTIBODY DETECTION; ANTIBODY SPECIFICITY; ARTICLE; COMPUTER ANALYSIS; CYTOTOXICITY TEST; HUMAN; LYMPHOCYTOTOXICITY; MAJOR CLINICAL STUDY; THROMBOCYTE TRANSFUSION;

ANTIBODIES; ANTIBODY SPECIFICITY; ANTIGENS, HUMAN PLATELET; BLOOD DONORS; BLOOD PLATELETS; CYTOTOXICITY TESTS, IMMUNOLOGIC; EPITOPES; HISTOCOMPATIBILITY; HISTOCOMPATIBILITY ANTIGENS CLASS I; HUMANS; IMMUNIZATION; RETROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY; SOFTWARE;

EID: 0032776866     PISSN: 00411132     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1537-2995.1999.39070772.x     Document Type: Article

References (37)

1. Konoeda Y, Terasaki PI, Wakisaka A, et al. Public determinants of HLA indicated by pregnancy antibodies. Transplantation 1986;41:253-9.
2. Duquesnoy RJ, White LT, Fierst JW, et al. Multiscreen serum analysis of highly sensitized renal dialysis patients for antibodies toward public and private HLA class I determinants. Transplantation 1990;50:427-37.
3. Rodey GE, Revels K, Fuller TC. Epitope specificity of HLA class I alloantibodies: II. Stability of cross-reactive group antibody patterns over extended time periods. Transplantation 1997;63:885-93.
4. Rodey GE, Neylan JF, Whelchel JD, et al. Epitope specificity of HLA class I alloantibodies. I. Frequency analysis of anti-bodies to private versus public specificities in potential transplant recipients. Hum Immunol 1994;39:272-80.
5. Lane TA, Anderson KC, Goodnough LT, et al. Leukocyte reduction in blood component therapy. Ann Intern Med 1992;117:151-62.
6. Thompson JS, Bryne JE, Hempel HO, et al. Computer algorithm that predicts both acceptable and unacceptable private and public HLA class I antigens in highly sensitized patients. Transplant Proc 1993;25:251-4.
7. Brubaker DB. Clinical significance of white cell antibodies in febrile nonhemolytic transfusion reactions. Transfusion 1990;30:733-7.
8. Dzieczkowski JS, Barrett BB, Nester D, et al. Characterization of reactions after exclusive transfusion of white cell-reduced cellular blood components. Transfusion 1995;35:20-5.
9. Phekoo KJ, Hambley H, Schey SA, et al. Audit of practice in platelet refractoriness. Vox Sang 1997;73:81-6.
10. O'Connell BA, Lee EJ, Rothko K, et al. Selection of histocompatible apheresis platelet donors by cross-matching random donor platelet concentrates. Blood 1992;79:527-31.
11. Chow MP, Yung CH, Hu HY, et al. Platelet crossmatching with lymphocytotoxicity test: an effective method in alloimmunized Chinese patients. Transfusion 1991;31:595-9.
12. McFarland JG. Matched apheresis platelets. In: McLeod BC, Price TH, Drew MJ, eds. Apheresis: principles and practice. Bethesda: AABB Press, 1997:171-91.
13. Zingsem J, Zimmermann R, Weisbach V, et al. Comparison of COBE white cell-reduction and standard plateletapheresis protocols in the same donors. Transfusion 1997;37:1045-9.
14. Wagner SJ, Friedman LI, Dodd RY. Transfusion-associated bacterial sepsis. Clin Microbiol Rev 1994;7:290-302.
15. Bodmer JG, Marsh SG, Albert ED, et al. Nomenclature for factors of the HLA system, 1996. Vox Sang 1997;73:105-30.
16. Terasaki PI, McClelland JD. Microdroplet assay of human serum cytotoxins. Nature 1964;204:998-1000.
17. Vartdal F, Gaudernack G, Funderud S, et al. HLA class I and II typing using cells positively selected from blood by immunomagnetic isolation - a fast and reliable technique. Tissue Antigens 1986;28:301-12.
18. Ray JG Jr, ed. NIAID manual of tissue typing techniques. DHEW publication (NIH) no. 80-545. Bethesda, MD: National Institute of Allergy and Infectious Diseases, 1979.
19. Colombani J, Lepage V, Raffoux C, Colombani M. HLA typing with monoclonal antibodies: evaluation of 356 HLA monoclonal antibodies including 181 studied during the 10th International Histocompatibility Workshop. Tissue Antigens 1989;34:97-110.
20. Marsh SG, Krausa P, Bodmer JG. A preliminary analysis of the 11th International Histocompatibility Workshop monoclonal antibodies. Tissue Antigens 1990;36:180-6.
21. Parham P, Belich M, Hildebrand WH, et al. Correlation of serology with the structures of HLA class I molecules. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991: proceedings of the Eleventh International Histocompatibility Workshop and Conference, volume 1. Oxford: Oxford University Press, 1992:542-59.
22. Parham P, Arnett KL, Adams EJ, et al. The HLA-B73 antigen has a most unusual structure that defines a second lineage of HLA-B alleles. Tissue Antigens 1994;43:302-13.
23. Parham P, Lawlor DA, Salter RD, et al. HLA-A, B, C: patterns of polymorphism in peptide-binding proteins. In: Dupont B, ed. Immunobiology of HLA. New York: Springer-Verlag, 1989:10-33.
24. Tongio MM, Betuel H, Gandini E, et al. Antigen society no. 114: HLA-C. In: Tsuji K, Aizawa M, Sasazuki T, eds. HLA 1991: proceedings of the Eleventh International Histocompatibility Workshop and Conference, volume 1. Oxford: Oxford University Press, 1992:340-4.
25. Madrigal JA, Hildebrand WH, Belich MP, et al. Structural diversity in the HLA-A10 family of alleles: correlations with serology. Tissue Antigens 1993;41:72-80.
26. Hildebrand WH, Domena JD, Shen SY, et al. HLA-B15: a widespread and diverse family of HLA-B alleles. Tissue Antigens 1994;43:209-18.
27. Walker RH. Serum analysis. In: Mallory D, Fawcett K, eds. HLA techniques for blood bankers. Arlington: American Association of Blood Banks, 1984:105-27.
28. Zimmermann R, Büscher M, Linhardt C, et al. A survey of blood component use in a German university hospital. Transfusion 1997;37:1075-83.
29. Vengelen-Tyler V, ed. Technical manual. 12th ed. Bethesda: American Association of Blood Banks, 1993:287-308.
30. Noreen HJ. Interpretation of crossmatch tests. In: Phelan DL, Mickelson EM, Noreen HS, eds. The ASHI laboratory manual, 3rd ed. Lenexa, KS: The American Society for Histocompatibility and Immunogenetics, 1993:I.C.1.1.
31. Zachary AA, Klingman L, Thorne N, et al. Variations of the lymphocytotoxicity test. An evaluation of sensitivity and specificity. Transplantation 1995;60:498-503.
32. Leukocyte reduction and ultraviolet B irradiation of plate-lets to prevent alloimmunization and refractoriness to platelet transfusions. The Trial to Reduce Alloimmunization to Platelets Study Group. N Engl J Med 1997;337:1861-9.
33. Oksanen K, Kekomäki R, Ruutu T, et al. Prevention of alloimmunization in patients with acute leukemia by use of white cell-reduced blood components - a randomized trial. Transfusion 1991;31:588-94.
34. Zimmermann R, Wittmann G, Zingsem J, et al. Rapid-screening for antibodies against cross-reacting HLA class I epitopes (abstract). Infusionsther Transfusionsmed 1994;21(Suppl):103-4.
35. Rodey GE, Fuller TC. Public epitopes and the antigenic structure of the HLA molecules. Crit Rev Immunol 1987;7:229-67.
36. Kotsch K, Wehling J, Kohler S, Blasczyk R. Sequencing of HLA class I genes based on the conserved diversity of the noncoding regions: sequencing-based typing of the HLA-A gene. Tissue Antigens 1997;50:178-91.
37. Binder T, Wehling J, Huhn D, Blasczyk R. Increased diversity within the HLA-A*66 group: implications for matching in unrelated bone marrow transplantation. Tissue Antigens 1997;50:77-82.